Elevance Health Inc. closed 31.17% below its 52-week high of $567.26, which the company reached on September 3rd.

The stock's fall snapped a three-day winning streak.

The Roundhill Magnificent Seven exchange-traded fund has risen 1.5% this year, helped by Meta and Amazon reaching all-time ...

Elevance Health Inc.'s stock rose 2% Thursday and boosted other health-insurance stocks after the company delivered better-than-expected earnings and forecast growth for 2025, easing investor concerns ...

Specifically, analysts expect S&P 500 companies in aggregate to report revenue growth of 5.8% and earnings growth of 14.8% in ...

Premium revenue is expected to rise in the low double-digit percentage range, while product revenue rises in the low single-digit range and service fees come in flat year-over-year. Overall, operating ...

PepsiCo's revenue fell slightly in the fourth quarter as North American consumers continued to pull back on purchases of ...

Novo Nordisk shares rose sharply after the Danish pharmaceutical giant said an experimental weight-loss shot helped patients ...

ResMed reported robust earnings for the second quarter of fiscal 2025, surpassing expectations and showcasing strong growth in revenue and profitability.

Analysts expected earnings of $6.73 per share in the fourth quarter on $101.6 billion in revenue, according to the data firm FactSet. UnitedHealth operates the nation’s largest health insurer, ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 0243 GMT – Breathing-tech provider ResMed doesn’t get enough ...

T-Mobile US exceeded earnings expectations with strong postpaid customer growth and significant service revenue increases.